Pai AB - Search Results

1

Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.

Pai AB. Pai AB. Ann N Y Acad Sci. 2017 Nov;1407(1):17-25. doi: 10.1111/nyas.13461. Epub 2017 Oct 13. Ann N Y Acad Sci. 2017. PMID: 29027212 Free article. Review.

2

In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.

Pai AB, Pai MP, Meyer DE, Bales BC, Cotero VE, Zheng N, Jiang W. Pai AB, et al. Among authors: pai mp. Regul Toxicol Pharmacol. 2018 Aug;97:17-23. doi: 10.1016/j.yrtph.2018.05.014. Epub 2018 May 29. Regul Toxicol Pharmacol. 2018. PMID: 29857115 Free PMC article.

3

Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.

Conner TA, McQuade C, Olp J, Pai AB. Conner TA, et al. Among authors: pai ab. Biometals. 2012 Oct;25(5):961-9. doi: 10.1007/s10534-012-9562-6. Epub 2012 Jun 17. Biometals. 2012. PMID: 22706571 Clinical Trial.

4

Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.

Pai AB, Conner T, McQuade CR, Olp J, Hicks P. Pai AB, et al. Biometals. 2011 Aug;24(4):603-13. doi: 10.1007/s10534-011-9409-6. Epub 2011 Jan 13. Biometals. 2011. PMID: 21229380 Clinical Trial.

5

Considerations and challenges in defining optimal iron utilization in hemodialysis.

Charytan DM, Pai AB, Chan CT, Coyne DW, Hung AM, Kovesdy CP, Fishbane S; Dialysis Advisory Group of the American Society of Nephrology. Charytan DM, et al. Among authors: pai ab. J Am Soc Nephrol. 2015 Jun;26(6):1238-47. doi: 10.1681/ASN.2014090922. Epub 2014 Dec 26. J Am Soc Nephrol. 2015. PMID: 25542967 Free PMC article. Review.

6

Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?

Souza E, Cho KH, Harris ST, Flindt NR, Watt RK, Pai AB. Souza E, et al. Among authors: pai ab. Expert Opin Investig Drugs. 2020 Aug;29(8):831-844. doi: 10.1080/13543784.2020.1777276. Epub 2020 Jun 16. Expert Opin Investig Drugs. 2020. PMID: 32476498 Review.

7

Approaches to Medication Management in Patients with Kidney Failure Opting for Conservative Management.

Cho KH, Ashjian EJ, Smith M, Pai AB. Cho KH, et al. Among authors: pai ab. Nephrol Nurs J. 2020 Jul-Aug;47(4):319-371. Nephrol Nurs J. 2020. PMID: 32830938 Review.

8

Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury.

Pai AB, Divine H, Marciniak M, Morreale A, Saseen JJ, Say K, Segal AR, Norton JM, Narva AS. Pai AB, et al. Ann Pharmacother. 2019 Jan;53(1):95-100. doi: 10.1177/1060028018789174. Epub 2018 Jul 18. Ann Pharmacother. 2019. PMID: 30019916

9

Iron-based phosphate binders--a new element in management of hyperphosphatemia.

Pai AB, Jang SM, Wegrzyn N. Pai AB, et al. Expert Opin Drug Metab Toxicol. 2016;12(1):115-27. doi: 10.1517/17425255.2016.1110573. Epub 2015 Nov 16. Expert Opin Drug Metab Toxicol. 2016. PMID: 26572591 Review.

10

Vancomycin dosing in high flux hemodialysis: a limited-sampling algorithm.

Pai AB, Pai MP. Pai AB, et al. Among authors: pai mp. Am J Health Syst Pharm. 2004 Sep 1;61(17):1812-6. doi: 10.1093/ajhp/61.17.1812. Am J Health Syst Pharm. 2004. PMID: 15462252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters